December 2016
Correction: Use J9310 for rituximab to treat patients with Devic disease
The benefit and medical policy for procedure code J9310 identified the wrong drug in the November billing chart. It should have read:
Blue Cross Blue Shield of Michigan has approved rituximab, 100 mg for off- label use to treat patients with neuromyelitis optica, also known as Devic disease, when reported with procedure code J9310 and ICD 10 diagnosis G36.0.
The physician who prescribes this drug for off-label use must determine the appropriate dose when used other than that approved by the FDA. |